Valuation: Guided Therapeutics, Inc.

Market Cap 2.7Cr 2.36Cr 2.17Cr 2.02Cr 3.84Cr 257.37Cr 3.9Cr 26Cr 10Cr 126.51Cr 10Cr 9.93Cr 435.94Cr P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 2.99Cr 2.61Cr 2.4Cr 2.24Cr 4.25Cr 284.75Cr 4.31Cr 29Cr 11Cr 139.97Cr 11Cr 11Cr 482.33Cr EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
1 day+14.29%
1 week+7.69%
Current month+16.67%
1 month+22.81%
3 months+16.67%
6 months-48.15%
Current year-48.15%
1 week 0.2
Extreme 0.2001
0.28
1 month 0.18
Extreme 0.1805
0.34
Current year 0.17
Extreme 0.17
0.54
1 year 0.12
Extreme 0.1231
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
5,760
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 70 01/12/2016
Director/Board Member 76 10/04/2006
Chairman 67 01/10/2013
Date Insider Type Main position Quantity % Market Cap.
10/03Free

Director

1,10,000 0.1316%
10/03Others

Director

10 0.9747%
10/03Free

Chairman

1,10,000 0.1316%
Change 5-day change 1-year change 3-year change Capi.($)
+14.29%+7.69%+5.46%+24.44% 2.7Cr
+1.97%+3.50%+22.37%+0.32% 19TCr
+5.87%+6.59%-21.20%+24.59% 15TCr
+2.17%+2.44%-2.26%-17.53% 14TCr
+4.83%+2.13%-56.44%-16.55% 6.71TCr
+2.59%+5.18%+22.53%+0.04% 5.43TCr
+0.03%+1.66%-26.25%-32.57% 4.46TCr
-2.02%-3.56%+8.31%+8.68% 3.69TCr
+0.31%+0.64%+7.78%+42.30% 3.72TCr
+1.09%+0.96%-13.87%-19.29% 2.98TCr
Average +2.52%+2.73%-5.36%+1.44% 7.56TCr
Weighted average by Cap. +1.52%+3.35%-3.59%+0.10%

Financials

2024 2025
Net sales 7T 6.12T 5.62T 5.24T 9.94T 7L 10.09T 67.51T 26.25T 3L 26.28T 25.71T 11.29L 8L 7L 6L 6L 10.89L 7.3Cr 11.06L 73.98L 28.76L 3.59Cr 28.79L 28.17L 12Cr
Net income -24.17L -21.13L -19.42L -18.1L -34.33L -23Cr -34.85L -2.33Cr -90.62L -11Cr -90.72L -88.78L -39Cr -31.96L -27.94L -25.68L -23.93L -45.39L -30Cr -46.08L -3.08Cr -1.2Cr -15Cr -1.2Cr -1.17Cr -52Cr
Net Debt 17.71L 15.48L 14.23L 13.26L 25.15L 17Cr 25.54L 1.71Cr 66.4L 8.29Cr 66.48L 65.05L 29Cr 28.76L 25.14L 23.11L 21.54L 40.85L 27Cr 41.47L 2.77Cr 1.08Cr 13Cr 1.08Cr 1.06Cr 46Cr
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
02/26/02 $0.2800 +14.29% 5,570
01/26/01 $0.2450 +2.08% 11,276
30/26/30 $0.2400 +19.94% 200
29/26/29 $0.2001 -16.62% 3,771
26/26/26 $0.2400 -7.69% 106
  1. Stock Market
  2. Stocks
  3. GTHP Stock